跳至主要内容
临床试验/CTRI/2011/12/002243
CTRI/2011/12/002243已完成不适用

Prospective dengue seroprevalence study in 5 to 10 year-old children in India

Sanofi Pasteur SA1 个研究点 分布在 1 个国家目标入组 3,230 人开始时间: 2011年9月22日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3,230
试验地点
1
主要终点
Percentage of participants with dengue specific IgG antibodies in serum samples

研究概览

简要总结

This is a descriptive prospective community-based seroprevalence study in a sample of children registered in the health centers to assess the prevalence of dengue-specific antibodies in order to assess if there has been dengue transmission in the community in recent years.xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /

研究设计

研究类型
Observational

入排标准

年龄范围
5.00 Year(s) 至 10.00 Year(s)(—)
性别
All

入选标准

  • Aged between 5 and 10 year-old on the day of inclusion.
  • Healthy child as reported by the parent or legally qualified guardian.
  • Being registered in selected study site.
  • Provision of the informed consent form signed by at least one parent or legally qualified guardian.
  • For children between 8 and 10 years old, provision of the assent form signed.

排除标准

  • 未提供

结局指标

主要结局

Percentage of participants with dengue specific IgG antibodies in serum samples

时间窗: Day 0

次要结局

  • Prevalence of positive samples with dengue specific serotype DENV 1, 2,3 and/or 4(Day 0)
  • Prevalence of positive serum samples with JEV specific IgG antibodies(Day 0)

研究者

发起方
Sanofi Pasteur SA
申办方类型
Pharmaceutical industry-Global

研究点 (1)

Loading locations...

相似试验